Combination of anticholinergics, glucocorticoids, beta2-ag0nists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases

摘要

The invention relates to novel combinations based on anticholinergics, ² 2 -adrenoceptor agonists, and glucocorticoids, process for production and its use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.